Fact-checked by Grok 2 weeks ago

Body load

Body load refers to the physical sensations or discomforts induced by psychoactive drugs, particularly serotonergic psychedelics, encompassing transient somatic symptoms such as nausea, tension, or general unease that accompany the altered mental states produced by these substances.^[1] This term, commonly employed within psychopharmacological research and user reports, highlights the bodily dimension of drug experiences distinct from purely psychological effects.^[2] In studies examining the subjective effects of psychedelics like LSD, psilocybin, or novel compounds such as 5-MeO-MIPT, body load is quantified as a key component influencing overall trip quality, often varying by substance and dosage.^[3] For instance, certain tryptamines and phenethylamines are noted for higher body load profiles, including stimulant-like or entactogenic physical responses, which can range from mild discomfort to overwhelming sensations that detract from the experience.^[4] Researchers utilize self-report scales and qualitative analyses to assess these effects, revealing patterns such as increased heart rate, gastrointestinal distress, or perceptual distortions tied to bodily awareness during intoxication.^[5] The concept underscores the holistic impact of psychedelics on both mind and body, with implications for therapeutic applications where minimizing body load may enhance safety and efficacy in clinical settings.^[6] Factors like set, setting, and individual physiology further modulate body load, making it a critical variable in phenomenological studies of consciousness alteration.^[7]

Overview

Definition

Body load refers to the unpleasant physical or tactile sensations induced by psychoactive drugs, particularly serotonergic psychedelics, encompassing transient somatic symptoms such as nausea, discomfort, and vomiting that occur especially during the onset of effects.^[1] These sensations are distinct from the psychological alterations or perceptual distortions associated with such substances, focusing instead on corporeal experiences that can range from mild unease to significant physical burden.^[8] The term "body load" originated within online psychonaut communities in the early 2000s, such as those documented on Erowid, where it was employed in user experience reports to articulate the somatic discomfort accompanying psychedelic trips, with early usages appearing in reports from 2000 onward.^[9] This nomenclature has since been adopted in scientific literature to describe these physical side effects without implying pathological conditions.^[4] In contrast to "headspace," which denotes the mental or cognitive shifts in thought patterns and mood, or "visuals," referring to hallucinatory perceptual changes, body load is strictly corporeal, emphasizing the body's physiological response rather than mind-altering or sensory phenomena.^[3]

Characteristics

Body load is characterized by a range of tactile and somatic sensations induced by psychoactive substances, particularly psychedelics, often manifesting as physical discomfort or unease that accompanies altered mental states. These sensations are typically described as unpleasant, encompassing feelings of heaviness in the limbs, muscle tension, internal pressure, or restlessness, which can create a sense of bodily burden during the experience. In some cases, users report more intense manifestations, such as nausea, headaches, or jaw clenching, contributing to an overall perception of physical strain that may overshadow psychological effects.^[8] The intensity and nature of body load exhibit significant variability across individuals and substances, influenced by factors such as dosage, the user's mindset (set), and environmental context (setting). At threshold doses, these sensations are common but not universal, ranging from mild discomfort that allows functional movement to more debilitating unease that limits physical activity. For instance, certain serotonergic psychedelics like phenethylamines tend to produce higher incidences of somatic symptoms compared to tryptamines or lysergamides, with transient effects like gastrointestinal distress appearing more frequently in the former.^[1]^[8] This variability underscores body load as a subjective component of the drug experience, where some individuals may perceive it as a vibrating or stimulating energy, while others experience it as overwhelmingly negative stress on the body. Research analyzing user reports highlights that body load often correlates with specific pharmacological profiles, such as affinities for monoamine transporters, but remains highly personal, potentially exacerbated by inexperience or higher doses.^[5]^[8]

Physiological Effects

Common Sensations

Body load in psychedelic use is commonly characterized by a range of unpleasant physical sensations, including nausea, muscle tension, gastrointestinal discomfort, dehydration manifested as dry mouth, tremors, elevated heart rate, and blood pressure.^[10]^[11] These symptoms often arise during the onset or peak phases of the experience and can significantly influence the overall subjective quality of the trip.^[10] Nausea stands out as one of the most prevalent sensations, affecting approximately 13-71% of users depending on the specific psychedelic substance, with psilocybin reports indicating 13% in one study, while ayahuasca users experience it in up to 71% of cases.^[12] Gastrointestinal discomfort, such as cramping or diarrhea, accompanies nausea in many instances and contributes to overall unease.^[10] Muscle tension frequently manifests as tightness in the torso or limbs, while tremors may present as subtle shaking or involuntary twitches, reported in up to 67% of psilocybin sessions as a sensation of the body vibrating.^[10]^[12] Dehydration-related dry mouth exacerbates feelings of discomfort, often prompting users to sip fluids during the experience.^[10] Beyond these primary symptoms, users frequently describe more nuanced sensory experiences, such as an "electric buzzing" throughout the body, akin to a vibrating or humming energy.^[13] Cold sweats may occur intermittently, adding to the sense of physical instability.^[14] Additionally, some reports highlight a sense of bodily disconnection, where individuals feel detached from their physical form, contributing to a disjointed proprioception during the altered state.^[15] These experiential details vary in intensity but are recurrent themes in user accounts from harm reduction resources.^[10]

Duration and Intensity

Body load, the physical discomfort associated with certain psychoactive substances, typically follows a predictable temporal profile aligned with the overall acute effects of these compounds. For most orally ingested psychedelics, onset occurs within 20-90 minutes, as the active metabolites begin to interact with serotonin receptors in the central nervous system, leading to initial somatic sensations; this varies by substance (e.g., 20-40 minutes for psilocybin, 30-60 minutes for LSD).^[11]^[16] Peak intensity is generally reached between 1-4 hours post-ingestion, when physiological responses such as increased heart rate, blood pressure, and gastrointestinal activity are most pronounced (e.g., 60-90 minutes for psilocybin, 2-3 hours for LSD).^[11]^[16] Resolution usually happens over 4-12 hours, with residual effects fading as drug concentrations decline, though mild discomfort like fatigue may linger briefly (e.g., 4-6 hours for psilocybin, 8-12 hours for LSD).^[11]^[16] The intensity of body load is often assessed subjectively using validated scales that quantify somatic effects, such as the Hallucinogen Rating Scale (HRS), which includes a somaesthesia subscale measuring physical perceptions like nausea, tremors, and visceral sensations on a continuum from minimal to overwhelming.^[17]^[18] Intensities are categorized as mild (subtle background discomfort that does not disrupt normal activity), moderate (noticeable interference with movement or comfort, akin to mild flu-like symptoms), or severe (immobilizing sensations that dominate the experience and may require rest).^[17] These levels are derived from participant reports in controlled studies, where higher doses correlate with escalated somatic intensity, though individual thresholds vary.^[18] Adaptations of broader tools, like the Mystical Experience Questionnaire, sometimes incorporate physical discomfort ratings to contextualize overall experiential quality.^[19] Progression of body load can vary, building gradually from subtle cues during onset to full intensity at peak, or emerging more abruptly in sensitive individuals due to rapid receptor activation.^[16] This pattern mirrors the pharmacokinetics of the substances, with metabolism influencing the rate but not the core trajectory in typical cases.^[11] Such dynamics often amplify common sensations like nausea, underscoring the interplay between physical and perceptual effects.^[11]

Causes

Pharmacological Factors

Body load in psychedelics arises primarily from the agonism of serotonin 5-HT2A receptors, which are expressed not only centrally but also peripherally on vascular smooth muscle cells and in gastrointestinal tissues, leading to activation of the peripheral nervous system and resultant physical discomfort.^[20] This receptor activation triggers vasoconstriction through pathways involving tyrosine kinase and ERK phosphorylation, contributing to sensations of tension and heaviness by altering blood flow and vascular tone.^[20] Additionally, peripheral 5-HT2A agonism stimulates smooth muscle contraction in the gut, enhancing peristalsis and secretion via interactions with myenteric neurons and enterocytes, which can manifest as gastrointestinal distress.^[21] Tryptamines, as key alkaloids in many psychedelics, exacerbate these effects by mimicking serotonin and inducing its release from enterochromaffin cells in the gastrointestinal tract, thereby increasing motility and contributing to nausea and cramping.^[22] This peripheral serotonin surge also activates 5-HT3 receptors, ligand-gated ion channels that amplify excitatory reflexes in the gut and stimulate vagal afferents, further promoting emetic responses through enhanced glutamate transmission in the brainstem.^[21] Such chemical properties distinguish tryptamine-based compounds by their direct influence on autonomic functions beyond central hallucinogenic actions. The intensity of body load correlates strongly with dosage, as higher amounts of these agonists lead to greater occupancy of peripheral 5-HT2A and 5-HT3 receptors, amplifying neurotransmitter release and downstream signaling.^[23] For instance, vasoconstrictive effects exhibit dose-dependency, with elevated levels causing more pronounced hemodynamic changes and physical strain.^[24] Threshold effects are evident, where body load becomes noticeable only above minimal doses that saturate peripheral receptors, beyond which incremental increases heighten somatic burden without proportional gains in perceptual alterations.^[24]

Individual Variables

Individual differences in biological, psychological, and environmental factors significantly modulate the experience of body load, the physical sensations accompanying psychedelic use, independent of the substance's intrinsic properties. Genetic variations, particularly in cytochrome P450 enzymes like CYP2D6, influence metabolism and thus the intensity and duration of physical effects for certain psychedelics. For instance, poor metabolizers of CYP2D6 exhibit approximately 75% higher exposure to LSD, leading to prolonged subjective effects that may intensify somatic discomfort, though autonomic responses such as heart rate remain unaffected.^[25] In contrast, for psilocybin's active metabolite psilocin, CYP2D6 metabolizes it extensively in vitro, but in vivo studies show no significant impact on plasma concentrations or effect variability across genotypes.^[26] Body weight and body mass index (BMI) do not predict the intensity of psilocybin-induced physical or subjective effects, with analyses across diverse weight ranges (49–113 kg) revealing no correlation in fixed or weight-adjusted dosing paradigms.^[27] Hydration status may indirectly affect body load, as psychedelics like LSD and psilocybin can induce excessive sweating and mild physiological arousal, potentially worsening discomfort in dehydrated individuals, though direct empirical links remain limited.^[28] Psychological factors, including pre-existing anxiety and user expectations, play a key role in amplifying body load through mechanisms akin to the nocebo effect. Heightened anxiety prior to ingestion can exacerbate perceived physical sensations such as nausea or tension, as negative anticipations prime the brain to interpret ambiguous bodily signals as adverse.^[29] This psychological modulation underscores the interplay between cognition and physiology in shaping body load. User surveys and phenomenological assessments indicate that such individual and contextual variables account for substantial inter-person variability in body load reports.

Contexts in Drug Use

Psychedelics

In classic psychedelics, psilocybin mushrooms frequently induce nausea and stomach cramps, particularly during the initial onset phase, as these gastrointestinal effects are prominent in user reports and dose-dependent in clinical settings.^[30]^[31] LSD, another archetypal serotonergic psychedelic, commonly produces jaw tension and vasoconstriction, manifesting as muscle tightness, clenching, and sensations of cold extremities due to reduced blood flow.^[32]^[33] Synthetic tryptamine variants exhibit varied body load profiles; 4-AcO-DMT is often described as having a milder physical impact than psilocybin mushrooms, with users selecting it specifically to minimize nausea and digestive discomfort while retaining similar perceptual effects.^[4] In contrast, DOI engenders substantial physical tension, including pronounced muscle stiffness and overall bodily discomfort that can overshadow its visual and cognitive alterations.^[8] User reports on platforms like Erowid highlight body load as a leading complaint among tryptamine experiences, with principal component analysis of these accounts identifying somatic discomfort—including nausea, tension, and gastrointestinal issues—as a core dimension accounting for notable variance in subjective effects.^[8]

Other Substances

In the context of dissociative drugs, body load manifests as profound physical disconnection and motor impairments. Ketamine, a prototypical dissociative anesthetic, often induces sensory numbness and a loss of bodily coordination, contributing to feelings of detachment from physical sensations during intoxication.^[34] These effects stem from its blockade of NMDA receptors, leading to analgesia and ataxia that can persist for hours, exacerbating the subjective experience of bodily unease.^[35] Similarly, phencyclidine (PCP) is associated with muscle rigidity and hyperreflexia, which can result in stiff, uncoordinated movements and increased physical tension, particularly at higher doses.^[36] Among stimulants, MDMA (ecstasy) commonly produces body load through involuntary jaw clenching (bruxism) and elevated body temperature (hyperthermia), which may lead to discomfort, dehydration, and muscle tension during use.^[37]^[38] These sensations are linked to its serotonergic and dopaminergic actions, often intensifying in warm environments or with physical activity, and can contribute to longer-term oral health issues if recurrent.^[39] Amphetamines, including methamphetamine, elicit restlessness, hyperactivity, and dehydration as key physical burdens, driven by sympathetic nervous system overstimulation that suppresses appetite and promotes excessive movement or sweating.^[40]^[41] Such effects heighten thirst and fatigue, potentially compounding into cardiovascular strain without adequate hydration.^[42] For opioids, body load is less central but can include itchiness (pruritus) and nausea, especially at high doses where mu-opioid receptor activation triggers histamine release and gastrointestinal upset.^[43]^[44] These symptoms, while not as prominently tied to perceptual alterations as in other classes, may nonetheless detract from comfort and are more frequent with agents like morphine or fentanyl in acute settings.^[45] Overall, these manifestations in non-psychedelic substances highlight overlapping tactile discomforts, though they differ mechanistically from serotonin-mediated effects.

Management

Mitigation Techniques

Preparation strategies for mitigating body load emphasize careful dosing and specific preparation methods to minimize physical discomfort, particularly nausea associated with psilocybin mushrooms. Starting with low doses and employing gradual titration—often summarized as "start low, go slow"—allows users to assess individual tolerance and reduce the intensity of somatic effects. This approach is recommended in psychedelic harm reduction guidelines to prevent overwhelming physical sensations.^[46] For psilocybin-containing mushrooms, the lemon tek method involves finely grinding dried mushrooms and soaking them in lemon juice for about 15-20 minutes before consumption, which anecdotal reports and harm reduction resources suggest can reduce nausea by aiding the conversion of psilocybin to psilocin and breaking down indigestible chitin in the fungal material.^[47]^[48] During the experience, maintaining hydration is a key practice to counteract potential dehydration from physical activity or gastrointestinal upset, as dehydration can exacerbate sensations of tension or discomfort. Consuming ginger, either raw or as tea, serves as an effective antiemetic for stomach issues, with its active compounds gingerol and shogaol acting on serotonin and muscarinic receptors to alleviate nausea, as supported by clinical evidence from studies on similar conditions like chemotherapy-induced vomiting.^[49] Anecdotal reports suggest that magnesium supplementation prior to or during use may help reduce muscular tension and anxiety-related body load. Post-use recovery focuses on replenishing the body to address residual fatigue and prevent compounding effects from repeated dosing. Adequate rest is essential, as psychedelic experiences can elevate neuroplasticity and emotional processing for days afterward, allowing time for integration without additional strain. Rehydrating with electrolyte-rich fluids helps restore balance after any fluid loss from nausea or sweating, while avoiding redosing is advised to prevent accumulation of physical load and permit full recovery.^[50]^[51] Body load, defined as the transient somatic discomforts such as nausea, tension, or tactile unease experienced during the acute phase of psychedelic intoxication, contrasts with conventional drug side effects that often persist or escalate into chronic toxicities. For example, whereas body load typically abates with the waning of psychoactive effects, serotonin syndrome—a severe adverse reaction from excessive serotonergic activity—presents with life-threatening symptoms including hyperthermia, seizures, and autonomic instability, primarily when psychedelics are combined with antidepressants or monoamine oxidase inhibitors.^[52]^[53] In distinction from the comedown, which refers to the post-peak phase characterized by rebound fatigue, irritability, and emotional depletion as neurotransmitter levels normalize after drug clearance, body load is confined to the initial onset and height of the experience, often intensifying alongside perceptual alterations.^[54]^[55] Although body load can overlap with nocebo responses, where negative expectations amplify perceived physical distress, its core mechanism remains pharmacological, driven by agonists at serotonin 5-HT2A receptors that disrupt sensory processing and autonomic function during intoxication.^[56]^[1] This experiential phenomenon, emphasizing subjective tactile burdens, has roots in late-20th-century psychonaut documentation, particularly in Alexander Shulgin's explorations of phenethylamines and tryptamines, where it delineates the somatic dimensions of altered states beyond purely psychological effects.^[57]

References

[1]
The use patterns of novel psychedelics: experiential fingerprints of ...
Apr 30, 2022 · For example, often a distinctive feature of serotonergic psychedelics is the 'body-load'; transient somatic symptoms (nausea, discomfort ...
[2]
Serotonergic Psychedelics: Experimental Approaches for Assessing ...
... psychedelic patterns) (Kometer and Vollenweider 2016), users typically report differences in their “body load,” stimulant and entactogenic effects, the ...
[3]
The Varieties of the Psychedelic Experience: A Preliminary Study of ...
Nov 8, 2018 · In terms of the “body load” component, the highest scores were observed for 5-MeO-MIPT, TMA-2 and 2C-T-2; in terms of the “preparation” ...
[4]
A qualitative descriptive analysis of effects of psychedelic ... - PMC
Jan 7, 2020 · NBOMe was described as having a heavy “body load,” and some described the high as being overwhelming. Similarly, others complained of ...
[5]
Trips and neurotransmitters: Discovering principled patterns across ...
Psychedelics probably alter states of consciousness by disrupting how the ... S1) flagged term collections revolving around body load and somatic ...
[6]
Powerful substances in tiny amounts: An interview study of ... - NIH
I found it very hard to follow instructions and had a huge body load. (ID5). Some respondents also found that microdosing could exacerbate certain conditions ...
[7]
Language as a Window Into the Altered State of Consciousness ...
... psychedelic tryptamines and phenethylamines, which include topics such as “changes to visual perception”, “body load”, “drug preparation”, “drug dependency ...<|control11|><|separator|>
[8]
The Varieties of the Psychedelic Experience: A Preliminary Study of ...
While the “body load” component also included such terms, others associated with stress and negative bodily sensations also presented high weights (e.g., “ ...Introduction · Materials and Methods · Results · Discussion<|control11|><|separator|>
[9]
https://erowid.org/experiences/exp.php?ID=2194
[10]
Ask Erowid : ID 2752 : What is "body load"?
Jul 17, 2001 · Examples of body load include muscle tension, tremors, nausea, pain, nystagmus (eyes twitching back and forth), dry mouth, diarrhea, altered ...
[11]
Adverse events in clinical treatments with serotonergic psychedelics ...
Aug 26, 2022 · The current paper aims to systematically review any AEs occurring during or after psychedelic treatments with classic/serotonergic hallucinogens ...
[12]
Ayahuasca - Erowid Exp - 'Choose Pleasure'
The whole time my head buzzed like the electric buzzing of a speaker, and the buzzing moved around. I thankfully had no visions (they seem to distract me ...
[13]
5-MeO-DIPT - Erowid Exp - 'Overwhelming Body Load'
At 8mg this body load was incredibly uncomfortable, so much so that it was the most memorable part of the trip. On 8mg I was also incredibly cold. Due to the ...
[14]
Psychedelic iatrogenic structural dissociation: an exploratory ...
This failure to synthesize may present as feelings of unreality, out-of-body experiences, bodily disconnection, analgesia, or impaired motor responses ( ...
[15]
Therapeutic use of psilocybin: Practical considerations for dosing ...
Relative to other psychedelics (such as MDMA, DMT, etc.), psilocybin has lower occurrence of seizures, hospital admissions and other serious adverse effects, ...Pharmacokinetics · Therapeutic Uses · Dosing And Administration...
[16]
Pharmacokinetics and Pharmacodynamics of Lysergic Acid ... - PMC
Feb 14, 2017 · The time to peak drug effect was 2.8 ± 0.8 h (range 1.2–4.6 h). After administration of the 200-µg dose of LSD, the times of onset and offset of ...
[17]
The Hallucinogen Rating Scale: Updated Factor Structure in a Large ...
The Hallucinogen Rating Scale (HRS) has been widely used to measure the subjective effects of psychedelics and other psychoactive substances.
[18]
(PDF) Psychometric assessment of the Hallucinogen Rating Scale
Aug 7, 2025 · ... scale and distributed on the following six subscales: somaesthesia (reflecting somatic effects including interoceptive, visceral, and ...
[19]
Psychedelics, Mystical Experience, and Therapeutic Efficacy - NIH
Jul 12, 2022 · Abstract. The mystical experience is a potential psychological mechanism to influence outcome in psychedelic therapy.Missing: discomfort | Show results with:discomfort
[20]
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling ...
Studies indicate that several effects of hallucinogens involve agonist activity at the serotonin 5-HT 2A receptor.
[21]
Psilocybin therapy and anorexia nervosa: a narrative review of ...
Apr 24, 2024 · Plausibly, enhanced peripheral 5-HT2A activation may explain the psilocybin-induced nausea frequently reported in clinical trials. ... 5-HT3 ...
[22]
Tryptophan metabolites get the gut moving - ScienceDirect.com
Feb 10, 2021 · Tryptamine induces the release of 5-HT by enteric neurons, stimulating gastrointestinal motility, and activates epithelial 5-HT4R, resulting ...
[23]
Psychedelic 5-HT 2A receptor agonism: neuronal signatures and ...
Sep 24, 2023 · These effects have been largely attributed to serotonin (5-hydroxytryptamine) receptor agonism, especially at the 5-HT2A receptor (5-HT2AR).
[24]
Acute dose-dependent effects of lysergic acid diethylamide in a ...
Oct 15, 2020 · Mean body weight was 69 kg and 78 and 60 kg in male and female participants, respectively. Accordingly, doses/body weight of LSD were 1.3-fold ...
[25]
Genetic influence of CYP2D6 on pharmacokinetics and acute ... - NIH
May 25, 2021 · CYP2D6 significantly influences LSD pharmacokinetics; non-functional CYP2D6 leads to longer half-lives, higher drug concentrations, and altered ...
[26]
In vitro and in vivo metabolism of psilocybin's active metabolite psilocin
Apr 28, 2024 · Approximately 29% of psilocin was metabolized by HLM, while recombinant CYP2D6 and CYP3A4 enzymes metabolized nearly 100% and 40% of psilocin, ...Missing: load | Show results with:load
[27]
Body mass index (BMI) does not predict responses to psilocybin
Nov 14, 2022 · This gap between evidence and practice is caused by the absence of studies clarifying the relationship between BMI, the acute psychedelic ...Missing: genetics | Show results with:genetics
[28]
Hallucinogens: LSD, Peyote, Psilocybin, PCP & Other Psychedelic ...
Hallucinogens, or psychedelics, are a group of drugs that alter a person's perception of reality. They also change a person's thoughts and feelings.Missing: frequency | Show results with:frequency
[29]
Considering the nocebo effect in the psychedelic discourse
May 10, 2024 · ... nocebo effect arising from the public discourse on psychedelics ... Key factors related to the psychedelic experience, including expectation ...
[30]
Set and setting - Wikipedia
Set and setting, when referring to a psychedelic drug experience or the use of other psychoactive substances, means one's mindset (shortened to "set") and ...<|separator|>
[31]
Psychedelics' Intoxicating Impact and Behavioural Dynamics
Nausea, body load. Table 2. Psychedelics: mechanism of action, targeted brain regions, and behavioural and potential side effects. 1.3.2 Brain regions ...
[32]
Psychedelics - Alcohol and Drug Foundation
Jun 6, 2025 · Effects of psychedelics · feelings of euphoria · sense of relaxation and wellbeing · seeing and hearing things that aren't there · confusion and ...What Are Psychedelics? · Explore Psychedelics On The... · Reducing HarmMissing: hydration | Show results with:hydration<|separator|>
[33]
The Evolved Psychology of Psychedelic Set and Setting: Inferences ...
Psychedelic research and treatment can adopt this shamanic biogenetic paradigm to optimize set, setting and ritual frameworks to enhance psychedelic effects.
[34]
Erowid Psilocybin Mushroom Vault : Effects
### Summary of Physical Effects and Side Effects Related to Psilocybin Mushrooms
[35]
The safety of psilocybin-assisted psychotherapy: A systematic review
The most common adverse events during and after sessions included elevated blood pressure, headaches, nausea, vomiting, fatigue and anxiety.Missing: side | Show results with:side
[36]
Erowid LSD (Acid) Vault : Effects
### Summary of Physical Effects Related to LSD Use
[37]
Lysergic Acid Diethylamide (LSD) and the Heart - PubMed Central
Jul 5, 2025 · These substances may also cause vasoconstriction, leading to ischemic or hemorrhagic strokes and acute coronary syndrome.
[38]
4-AcO-DMT - Erowid Exp - 'The Exorcism'
Feb 11, 2020 · Looking to expand on my consciousness and psychedelic experiences with different chemicals; I knew I wanted to try out psilocybin/psilocin and ...
[39]
Ketamine Toxicity - StatPearls - NCBI Bookshelf
Ketamine is a structural analog of the dissociative anesthetic and recreational drug phencyclidine (PCP).[1] Similar to phencyclidine, ketamine causes ...
[40]
[PDF] HALLUCINOGENS AND DISSOCIATIVE DRUGS - Nida.nih.gov
Dissociative drugs like PCP, ketamine, DXM, and Salvia divinorum may make a user feel out of control and disconnected from their body and environment. In ...
[41]
Phencyclidine Toxicity - StatPearls - NCBI Bookshelf
Sep 4, 2023 · PCP begins to cause symptoms at a dose of 0.05mg/kg, and a dose of ... muscle rigidity, ataxia, coma. Trauma - thorough examination for ...
[42]
[PDF] MDMA (Ecstasy) Abuse - NIDA
MDMA can also produce other adverse health effects, including involuntary jaw clenching, lack of appetite, mild detachment from oneself (depersonalization) ...
[43]
3,4-Methylenedioxymethamphetamine (MDMA) Toxicity - NCBI - NIH
Jan 17, 2024 · Other complications include increased psychomotor agitation or muscle activity (such as bruxism, restless legs, and jaw clenching), ...
[44]
Oral health effects of ecstasy (MDMA) and methamphetamine
Sep 12, 2025 · Bruxism and jaw clenching, frequent during MDMA use, are implicated in temporomandibular joint dysfunction and can lead to significant tooth ...
[45]
Neurobiology and Clinical Manifestations of Methamphetamine ...
Sep 30, 2016 · Short-term physiological effects of methamphetamine and amphetamine include loss of appetite, tachycardia, hypertension, tachypnea ...
[46]
Understanding the Mechanisms of Action and Effects of Drugs of ...
The effects of acute consumption in the case of amphetamine are altered consciousness, anxiety, restlessness, headache, anorexia, confusion, bruxism, psychosis ...
[47]
The Health Effect of Psychostimulants: A Literature Review - PMC
The sense of appetite and the need to sleep are suppressed; still the feeling of thirst can sometimes be enhanced even without a water deficit after MDMA use.
[48]
Four Strategies for Managing Opioid-Induced Side Effects in Older ...
This review describes four approaches to managing opioid-induced side effects that can be implemented both before and during opioid treatment.
[49]
Peripheral Opioids - Itch - NCBI Bookshelf - NIH
The side effects can be numerous and debilitating such as constipation, nausea, sedation, and pruritus. The prevalence of pruritus depends on the opioid used ...INTRODUCTION · PERIPHERAL µ-OPIOID... · PERIPHERAL κ-OPIOID...
[50]
The Useage of Opioids and their Adverse Effects in Gastrointestinal ...
Common adverse effects of opioid administration include sedation, dizziness, nausea, vomiting, constipation, dependency and tolerance, and respiratory ...
[51]
PTSF52 - Start Low, Go Slow | Psychedelics Today
PTSF52 – Start Low, Go Slow. March 26, 2021. In this week's Solidarity Fridays episode, ... And we want harm-reduction and we want laws and we want drug- ...
[52]
Combating Nausea: Basic Psilocybin Risk Reduction - PsiloHealth
Aug 26, 2025 · Nausea is one of the most notorious side effects of psilocybin mushroom ingestion. In some unfortunate cases, vomiting, stomach pains, and GI distress can ...Missing: load | Show results with:load
[53]
Does Lemon Tek Reduce Nausea from Shrooms? - Asana Recovery
While many users report reduced nausea with Lemon Tek, there is no solid scientific evidence to definitively prove this claim. The theory is that by pre- ...Does Lemon Tek Reduce Nausea... · What Is Lemon Tek? · Does Lemon Tek Really Reduce...
[54]
https://adf.org.au/insights/drug-comedowns/
[55]
MAPS Psychedelic Integration Station
Harm reduction is a critical part of responsible use of psychedelics. With proper support and integration, most of these challenges can become meaningful ...Why Integrate? · Domains Of Integration · A Note On 'good' And 'bad'...
[56]
Harm reduction practises for users of psychedelic drugs: a scoping ...
Oct 3, 2025 · Although the risks and harms of psychedelics from a physical perspective are low, psychedelic drugs carry a unique psychological risk profile ...Missing: load | Show results with:load
[57]
Serotonin syndrome - Symptoms & causes - Mayo Clinic
Lithium (Lithobid), a mood stabilizer; Illicit drugs, including LSD, ecstasy, cocaine and amphetamines; Herbal supplements, including St. John's wort, ginseng ...
[58]
Serotonin toxicity of serotonergic psychedelics - PubMed
Psychiatric disorders targeted by these psychedelic-assisted therapies are managed with serotonergic drugs like selective serotonin reuptake inhibitors (SSRIs) ...
[59]
Drug comedowns - Alcohol and Drug Foundation
Jan 30, 2023 · So, what causes a comedown? · how much of the drug you've taken and over what period of time · whether you took other drugs as well · the strength ...Missing: load | Show results with:load
[60]
The Comedown, Crash, or Rebound Effect of Drugs - Verywell Mind
The Comedown, Crash, or Rebound Effect of Drugs · Key Takeaways · What is the most important information I should know about drug rebound?
[61]
Harnessing placebo: Lessons from psychedelic science - PMC
Finally, in psychedelics research, pre-dosing session therapeutic alliance was found to predict the intensity of the acute psychedelic experience, which in turn ...
[62]
[PDF] TiHKAL: The Continuation, by Alexander and Ann Shulgin
was all about dealing with body load and discomfort." (with 12 mg, orally) "There was a very strange, almost paranoid session of listening to music, about ...